Oblato
Pre-clinicalOblato, Inc. is a pharmaceutical company focused on the development and commercialization of novel cancer therapeutics. Oblato has been developing OKN-007 for the treatment of brain cancers.
Founded
2018
Focus
Small Molecules
About
Oblato, Inc. is a pharmaceutical company focused on the development and commercialization of novel cancer therapeutics. Oblato has been developing OKN-007 for the treatment of brain cancers.
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile